Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-12 9:11 pm Purchase |
2025-03-11 | 13D | Outlook Therapeutics, Inc. OTLK |
GMS VENTURES & INVESTMENTS | 16,183,787 41.600% |
3,458,571 (+27.18%) |
Filing History |
| 2025-01-22 4:17 pm Purchase |
2025-01-17 | 13D | Outlook Therapeutics, Inc. OTLK |
GMS VENTURES & INVESTMENTS | 12,725,216 38.600% |
3,458,571 (+37.32%) |
Filing History |
| 2024-03-20 5:24 pm Purchase |
2024-03-18 | 13D | Outlook Therapeutics, Inc. OTLK |
GMS VENTURES & INVESTMENTS | 9,266,645 37.000% |
9,266,645 (New Position) |
Filing History |
| 2022-12-29 4:43 pm Purchase |
2022-12-28 | 13D | Outlook Therapeutics, Inc. OTLK |
GMS VENTURES & INVESTMENTS | 3,563,876 27.900% |
711,521 (+24.95%) |
Filing History |
| 2022-07-07 5:20 pm Purchase |
2022-07-05 | 13D | Outlook Therapeutics, Inc. OTLK |
GMS VENTURES & INVESTMENTS | 2,852,355 25.100% |
2,852,355 (New Position) |
Filing History |